Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GERN | Employee Stock Option (Right to buy) | Award | $0 | +500K | $0.00 | 500K | Aug 15, 2023 | Common Stock | 500K | $1.72 | Direct | F1 |
Id | Content |
---|---|
F1 | Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS. |